Why did PRVA's Q4 earnings surprise analysts positively?

Privia Health's Q4 earnings report exceeded analysts' expectations in several key areas, contributing to a positive surprise:

1. **Revenue Outperformance**: Privia Health reported revenue of $460.9 million for Q4, surpassing the anticipated $420.94 million. This 9.3% revenue beat reflects effective market expansion and growth in implemented providers.
2. **Earnings Per Share (EPS) Surprise**: The company's EPS for Q4 was $0.21, which significantly exceeded the forecast of $0.05. This substantial EPS surprise indicates strong profitability and operational efficiency.
3. **Adjusted EBITDA Growth**: Privia Health reported a 44% increase in adjusted EBITDA, reaching $24.9 million. This robust growth in EBITDA highlights the company's effective cost management and operational leverage.
4. **Free Cash Flow Strength**: With a free cash flow of $109.3 million for the year, Privia Health demonstrated strong financial health and liquidity. This is particularly noteworthy as it represents 121% of adjusted EBITDA, underscoring the company's ability to generate cash from operations.
5. **Provider Growth**: The company saw a 11.2% year-over-year increase in implemented providers, reaching 4,789 by the end of 2024. This growth in the provider network is crucial for Privia Health's expansion strategy and contributes to its revenue model.

These factors combined to create a positive earnings surprise, reflecting Privia Health's strategic execution and operational effectiveness.